Alba Galán[Author] - Search Results

Year	Number of Results
2002	1
2003	1
2004	1
2006	1
2007	1
2008	1
2009	1
2010	2
2011	1
2014	5
2015	1
2016	3
2017	6
2018	3
2019	3
2020	2
2021	2
2023	1
2024	0

1

Neuroprotection: Pro-survival and Anti-neurotoxic Mechanisms as Therapeutic Strategies in Neurodegeneration.

Saragovi HU, Galan A, Levin LA. Saragovi HU, et al. Among authors: galan a. Front Cell Neurosci. 2019 Jun 6;13:231. doi: 10.3389/fncel.2019.00231. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31244606 Free PMC article. Review.

2

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer.

Galan A, Papaluca A, Nejatie A, Matanes E, Brahimi F, Tong W, Hachim IY, Yasmeen A, Carmona E, Klein KO, Billes S, Dawod AE, Gawande P, Jeter AM, Mes-Masson AM, Greenwood CMT, Gotlieb WH, Saragovi HU. Galan A, et al. Front Oncol. 2023 Apr 14;13:1134763. doi: 10.3389/fonc.2023.1134763. eCollection 2023. Front Oncol. 2023. PMID: 37124505 Free PMC article.

3

Hepatocellular Carcinoma: Referral to a Transplantation Unit.

Triana P, Dore M, Romo MM, Gomez JJ, Galán AS, Hernandez F, Moreno AM, Encinas JL, Martinez L, Santamaria ML. Triana P, et al. Among authors: galan as. Eur J Pediatr Surg. 2017 Feb;27(1):16-19. doi: 10.1055/s-0036-1593385. Epub 2016 Oct 10. Eur J Pediatr Surg. 2017. PMID: 27723922

4

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.

Huang F, Gonçalves C, Bartish M, Rémy-Sarrazin J, Issa ME, Cordeiro B, Guo Q, Emond A, Attias M, Yang W, Plourde D, Su J, Gimeno MG, Zhan Y, Galán A, Rzymski T, Mazan M, Masiejczyk M, Faber J, Khoury E, Benoit A, Gagnon N, Dankort D, Journe F, Ghanem GE, Krawczyk CM, Saragovi HU, Piccirillo CA, Sonenberg N, Topisirovic I, Rudd CE, Miller WH Jr, Del Rincón SV. Huang F, et al. Among authors: galan a. J Clin Invest. 2021 Apr 15;131(8):e140752. doi: 10.1172/JCI140752. J Clin Invest. 2021. PMID: 33690225 Free PMC article.

5

Vaccination with Tumor-Ganglioside Glycomimetics Activates a Selective Immunity that Affords Cancer Therapy.

Tong W, Maira M, Roychoudhury R, Galan A, Brahimi F, Gilbert M, Cunningham AM, Josephy S, Pirvulescu I, Moffett S, Saragovi HU. Tong W, et al. Among authors: galan a. Cell Chem Biol. 2019 Jul 18;26(7):1013-1026.e4. doi: 10.1016/j.chembiol.2019.03.018. Epub 2019 May 16. Cell Chem Biol. 2019. PMID: 31105061 Free article.

6

Tertiary surgery for complicated repair of esophageal atresia.

Ortiz R, Galán AS, Martinez L, Dominguez E, Hernández F, Santamaria ML, Tovar JA. Ortiz R, et al. Among authors: galan as. Eur J Pediatr Surg. 2015 Feb;25(1):20-6. doi: 10.1055/s-0034-1386645. Epub 2014 Aug 21. Eur J Pediatr Surg. 2015. PMID: 25144352

7

Alternative Splicing of a Receptor Intracellular Domain Yields Different Ectodomain Conformations, Enabling Isoform-Selective Functional Ligands.

Brahimi F, Galan A, Jmaeff S, Barcelona PF, De Jay N, Dejgaard K, Young JC, Kleinman CL, Thomas DY, Saragovi HU. Brahimi F, et al. Among authors: galan a. iScience. 2020 Aug 10;23(9):101447. doi: 10.1016/j.isci.2020.101447. eCollection 2020 Sep 25. iScience. 2020. PMID: 32829283 Free PMC article.

8

Anesthetic effects of isoflurane and propofol on cerebrospinal fluid biochemical markers in healthy dogs.

Seisdedos A, Galán A, Carletti B, Quirós S, Funes F, Martín EM, Domínguez JM, Gómez R, Granados MM. Seisdedos A, et al. Among authors: galan a. Vet Clin Pathol. 2019 Jun;48(2):270-275. doi: 10.1111/vcp.12724. Epub 2019 May 9. Vet Clin Pathol. 2019. PMID: 31074074

9

Therapeutic Neuroprotection by an Engineered Neurotrophin that Selectively Activates Tropomyosin Receptor Kinase (Trk) Family Neurotrophin Receptors but Not the p75 Neurotrophin Receptor.

Brahimi F, Galan A, Siegel S, Szobota S, Sarunic MV, Foster AC, Saragovi HU. Brahimi F, et al. Among authors: galan a. Mol Pharmacol. 2021 Nov;100(5):491-501. doi: 10.1124/molpharm.121.000301. Epub 2021 Aug 31. Mol Pharmacol. 2021. PMID: 34470776

10

The route of administration influences the therapeutic index of an anti-proNGF neutralizing mAb for experimental treatment of Diabetic Retinopathy.

Barcelona PF, Galan A, Nedev H, Jian Y, Sarunic MV, Saragovi HU. Barcelona PF, et al. Among authors: galan a. PLoS One. 2018 Jun 21;13(6):e0199079. doi: 10.1371/journal.pone.0199079. eCollection 2018. PLoS One. 2018. PMID: 29927948 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

31 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year